Why technology standards are critical for Quantum-Safe Security

Safeguard Insights

November 8, 2010

Eli Lilly Agrees to Acquire Safeguard Scientifics Partner Company Avid Radiopharmaceuticals

For the second time in as many weeks, I am pleased to announce that a major player in the pharmaceutical industry has recognized the value…

Posted by Peter J. Boni

September 29, 2010

Safeguard Scientifics and Partner Company Avid Radiopharmaceuticals Honored with Life Sciences Awards

Today, we were honored by the Philadelphia Business Journal with the Inaugural Life Sciences Venture Impact Award, which “goes to the venture capital firm from…

Posted by James A. Datin

July 12, 2010

Bloomberg Businessweek says Avid likely to Beat GE, Bayer to Market

On the eve of the International Conference on Alzheimer’s Disease (ICAD), Bloomberg Businessweek’s Elizabeth Lopatto and Kanoko Matsuyama reported that Avid Radiopharmaceuticals, Inc., a Safeguard…

Posted by James A. Datin

June 24, 2010

New York Times puts Avid’s Technology Front and Center

Avid Radiopharmaceuticals was featured on the front page of The New York Times today. The article, “Promise Seen for Detection of Alzheimer’s,” by Gina Kolata (@ginakolata), highlights…

Posted by James A. Datin

April 15, 2010

Avid Radiopharmaceuticals Announces Positive Interim Results from Phase III Clinical Trial of Amyloid Imaging Agent Florbetapir F18

Our partner company, Avid Radiopharmaceuticals, announced positive interim results from the Phase III clinical trial of its amyloid imaging agent Florbetapir F18 for early diagnosis…

Posted by Peter J. Boni

March 31, 2010

Avid Radiopharmaceuticals Making Strides Toward Clinical Trial Milestone

I frequently attribute Safeguard Scientifics’ success to our disciplined strategy built on five strategic themes, which we refer to as M2C3. We leverage these themes…

Posted by Peter J. Boni

January 21, 2010

Avid Radiopharmaceuticals Presents at J.P. Morgan Investor Conference

Safeguard Scientifics’ partner company Avid Radiopharmaceuticals was invited to present its technology and growth strategy at the prestigious J.P. Morgan 28th Annual Healthcare Conference in…

Posted by James A. Datin

Content